Tailored AXIllary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS).
A multicenter randomized phase III trial.
Protocol SAKK 23/16 / IBCSG 57-18 / ABCSG-53, NCT03513614
Tailored AXIllary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS).
A multicenter randomized phase III trial.
Protocol SAKK 23/16 / IBCSG 57-18 / ABCSG-53, NCT03513614
A trial by SAKK - SWISS GROUP FOR CLINICAL CANCER RESEARCH
Introduction
The sponsor of the TAXIS study, which is being conducted in several countries, is the Swiss University Hospital Basel (USB). The initiator of the study and global study leader is Prof Walter Weber, MD.
In Germany, the study is being conducted by the German Breast Group in collaboration with Prof. Dr Heil (Heidelberg University Hospital) as LKP and Dr Krug as radiotherapist (University Hospital Schleswig-Holstein, Kiel Campus).
News
Trial is recruiting in Germany.
Design
Taxis Studiendesign
Contact
Jan Steffen
